PE20130776A1 - Derivados de quinolizidina e indolizidina - Google Patents
Derivados de quinolizidina e indolizidinaInfo
- Publication number
- PE20130776A1 PE20130776A1 PE2012002454A PE2012002454A PE20130776A1 PE 20130776 A1 PE20130776 A1 PE 20130776A1 PE 2012002454 A PE2012002454 A PE 2012002454A PE 2012002454 A PE2012002454 A PE 2012002454A PE 20130776 A1 PE20130776 A1 PE 20130776A1
- Authority
- PE
- Peru
- Prior art keywords
- indolizidine
- quinolizidine
- octahydro
- benzamide
- trifluoromethyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
SE REFIERE A COMPUESTOS DERIVADOS DE QUINOLIZIDINA E INDOLIZIDINA DE FORMULA (I-A) Y (I-B) DONDE: X ES UN ENLACE, UN GRUPO -CH2; R1,R2 Y R3 SON H, ALCOXI INFERIOR, ALQUILO INFERIOR SUSTITUIDO POR HALOGENO, S-ALQUILO INFERIOR, ENTRE OTROS. SON COMPUESTOS PREFERIDOS: 2-METOXI-6-METILSULFANIL-N-((1S, R; 9aR, S)-1-FENIL-OCTAHIDRO-QUINOLIZIN-1-IL)-4-TRIFLUOROMETIL-BENZAMIDA; 2-METOXI-6-METILSULFANIL-N-((8S, R; 8aR, S)-8-FENIL-OCTAHIDRO-INDOLIZIN-8-IL)-4-TRIFLUOROMETIL-BENZAMIDA; ENTRE OTROS. TAMBIEN SE REFIERE A UN PROCEDIMIENTO FARMACEUTICO. DICHO COMPUESTO ES UTIL PARA EL TRATAMIENTO DE LOS TRASTORNOS NEUROLOGICOS Y NEUROPSIQUIATRICOS.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10166776 | 2010-06-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20130776A1 true PE20130776A1 (es) | 2013-07-03 |
Family
ID=44314179
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2012002454A PE20130776A1 (es) | 2010-06-22 | 2011-06-17 | Derivados de quinolizidina e indolizidina |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US8143273B2 (es) |
| EP (1) | EP2585460B1 (es) |
| JP (1) | JP5659299B2 (es) |
| KR (1) | KR101431949B1 (es) |
| CN (1) | CN102947301B (es) |
| AR (1) | AR082766A1 (es) |
| AU (1) | AU2011269147A1 (es) |
| BR (1) | BR112012030886A2 (es) |
| CA (1) | CA2797874C (es) |
| CL (1) | CL2012003553A1 (es) |
| CO (1) | CO6630104A2 (es) |
| CR (1) | CR20120601A (es) |
| EA (1) | EA201291281A1 (es) |
| ES (1) | ES2523572T3 (es) |
| HK (1) | HK1179609A1 (es) |
| IL (1) | IL222602A0 (es) |
| MA (1) | MA34250B1 (es) |
| MX (1) | MX2012013580A (es) |
| PE (1) | PE20130776A1 (es) |
| SG (1) | SG186327A1 (es) |
| TW (1) | TWI412526B (es) |
| WO (1) | WO2011161008A1 (es) |
| ZA (1) | ZA201209089B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014199960A1 (ja) * | 2013-06-10 | 2014-12-18 | 大正製薬株式会社 | グリシントランスポーター阻害物質 |
| KR102380870B1 (ko) | 2019-06-19 | 2022-03-31 | 한양대학교 에리카산학협력단 | 퀴놀리지딘 화합물 및 그 제조방법 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA795318B (en) * | 1978-10-13 | 1980-09-24 | Hoffmann La Roche | Phenyl quinolizidines |
| NZ191763A (en) | 1978-10-13 | 1984-05-31 | Hoffmann La Roche | 7-beta-phenyl-quinolidines, intermediates and pharmaceutical compositions |
| EP0067565A1 (en) * | 1981-06-16 | 1982-12-22 | Beecham Group Plc | Pharmaceutically active compounds |
| JP2004510712A (ja) * | 2000-09-22 | 2004-04-08 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | オクタヒドロ−インドリジンおよびキノリジンおよびヘキサヒドロ−ピロリジン |
| WO2003055856A2 (en) * | 2001-10-17 | 2003-07-10 | Bristol-Myers Squibb Company | BICYCLIC LACTAM DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-α CONVERTING ENZYME (TACE) |
| FR2906251B1 (fr) | 2006-09-22 | 2008-11-07 | Sanofi Aventis Sa | Derives de pyrrolizine, indolizine et quinolizine, leur preparation et leur application en therapeutique |
| US20110306597A1 (en) * | 2008-06-18 | 2011-12-15 | James Michael Crawforth | Nicotinamide Derivatives |
-
2011
- 2011-06-16 US US13/161,534 patent/US8143273B2/en not_active Expired - Fee Related
- 2011-06-17 WO PCT/EP2011/060077 patent/WO2011161008A1/en active Application Filing
- 2011-06-17 MX MX2012013580A patent/MX2012013580A/es active IP Right Grant
- 2011-06-17 EA EA201291281A patent/EA201291281A1/ru unknown
- 2011-06-17 ES ES11726146.1T patent/ES2523572T3/es active Active
- 2011-06-17 AU AU2011269147A patent/AU2011269147A1/en not_active Abandoned
- 2011-06-17 JP JP2013515818A patent/JP5659299B2/ja active Active
- 2011-06-17 KR KR1020127032605A patent/KR101431949B1/ko active IP Right Grant
- 2011-06-17 CA CA2797874A patent/CA2797874C/en not_active Expired - Fee Related
- 2011-06-17 BR BR112012030886A patent/BR112012030886A2/pt not_active IP Right Cessation
- 2011-06-17 EP EP11726146.1A patent/EP2585460B1/en active Active
- 2011-06-17 PE PE2012002454A patent/PE20130776A1/es not_active Application Discontinuation
- 2011-06-17 SG SG2012091682A patent/SG186327A1/en unknown
- 2011-06-17 MA MA35397A patent/MA34250B1/fr unknown
- 2011-06-17 CN CN201180030484.9A patent/CN102947301B/zh active Active
- 2011-06-20 TW TW100121497A patent/TWI412526B/zh not_active IP Right Cessation
- 2011-06-21 AR ARP110102139A patent/AR082766A1/es unknown
-
2012
- 2012-10-10 CO CO12178886A patent/CO6630104A2/es active IP Right Grant
- 2012-10-22 IL IL222602A patent/IL222602A0/en unknown
- 2012-11-28 CR CR20120601A patent/CR20120601A/es unknown
- 2012-11-30 ZA ZA2012/09089A patent/ZA201209089B/en unknown
- 2012-12-17 CL CL2012003553A patent/CL2012003553A1/es unknown
-
2013
- 2013-06-05 HK HK13106614.8A patent/HK1179609A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CN102947301B (zh) | 2015-02-11 |
| SG186327A1 (en) | 2013-01-30 |
| EP2585460A1 (en) | 2013-05-01 |
| EP2585460B1 (en) | 2014-10-01 |
| MX2012013580A (es) | 2013-01-24 |
| CO6630104A2 (es) | 2013-03-01 |
| BR112012030886A2 (pt) | 2016-11-08 |
| WO2011161008A1 (en) | 2011-12-29 |
| CA2797874C (en) | 2018-04-24 |
| EA201291281A1 (ru) | 2013-06-28 |
| MA34250B1 (fr) | 2013-05-02 |
| AU2011269147A1 (en) | 2012-11-01 |
| US8143273B2 (en) | 2012-03-27 |
| CL2012003553A1 (es) | 2013-03-22 |
| TWI412526B (zh) | 2013-10-21 |
| US20110313165A1 (en) | 2011-12-22 |
| CR20120601A (es) | 2013-01-03 |
| IL222602A0 (en) | 2012-12-31 |
| JP2013529609A (ja) | 2013-07-22 |
| KR20130028756A (ko) | 2013-03-19 |
| CN102947301A (zh) | 2013-02-27 |
| ES2523572T3 (es) | 2014-11-27 |
| CA2797874A1 (en) | 2011-12-29 |
| HK1179609A1 (en) | 2013-10-04 |
| KR101431949B1 (ko) | 2014-08-19 |
| ZA201209089B (en) | 2013-08-28 |
| AR082766A1 (es) | 2013-01-09 |
| JP5659299B2 (ja) | 2015-01-28 |
| TW201206928A (en) | 2012-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20160589A1 (es) | Heteroaril-ciclohexil-tetraazabenzo[e]azulenos como antagonistas de los receptores de vasopresina v1a | |
| EA201490579A1 (ru) | Новые хиральные n-ацил-5,6,7,(8-замещенные)тетрагидро-[1,2,4]триазоло[4,3-а]пиразины как селективные антагонисты рецептора nk-3, фармацевтическая композиция, способы применения при нарушениях, опосредованных nk-3 рецепторами, и их хиральный синтез | |
| EA201490807A1 (ru) | Новые замещенные имидазопиримидины как модуляторы рецептора gpbar1 | |
| MX2013014470A (es) | Compuestos de pirazolo[3,4-d]pirimidina y su uso como inhibidores pde2 y/o inhibidores cyp3a4. | |
| PE20130155A1 (es) | Derivados de ariletinilo | |
| UA113968C2 (xx) | Тверді форми нематоцидних сульфонамідів | |
| PE20140250A1 (es) | Derivados de piperidina puenteada | |
| PE20142293A1 (es) | Pirimidinas y triazinas fusionadas sustituidas y su uso | |
| PE20141557A1 (es) | Derivado de pirazoloquinolina | |
| PE20120418A1 (es) | DERIVADOS DE PIRIDO[2,3-b]PIRAZINA COMO INHIBIDORES DE POLI (ADP-RIBOSA) POLIMERASA (PARP) | |
| PE20200016A1 (es) | Imidazopirimidinas diazabiciclicas sustituidas y su uso para el tratamiento de trastornos respiratorios | |
| NZ603800A (en) | Substituted 5-fluoro-1h-pyrazolopyridines and use thereof | |
| EA033513B1 (ru) | Способы получения хинолиновых соединений и фармацевтических композиций, содержащих такие соединения | |
| ECSP11011288A (es) | Derivados de indol como antagonistas del receptor crth2 | |
| PE20150777A1 (es) | Derivados triciclicos de quinolinas y de quinoxalinas | |
| PE20130401A1 (es) | Heteroaril-ciclohexil-tetraazabenzo[e]azulenos | |
| NZ605432A (en) | 2-(arylamino)-3h-imidazo[4,5-b]pyridine-6-carboxamide derivatives and their use as mpges-1 inhibitors | |
| MX2013008431A (es) | Antagonista del receptor de mineralocorticoides. | |
| PE20090049A1 (es) | Derivados de piridopirimidina como moduladores de la actividad de pde 4 | |
| MD4583B1 (ro) | Piridinone biciclice noi | |
| PE20121438A1 (es) | Derivados de imidazopiridina o imidazopirimidina como inhibidores de fosfodiesterasa 10a | |
| UY29204A1 (es) | Compuestos de imidazo(1,2-a)piridina, composiciones, usos y métodos relacionados | |
| PE20141553A1 (es) | Compuestos de triazolopiridina como inhibidores de la ped10a | |
| DOP2020000118A (es) | Proceso para la preparación de derivados de quinolina | |
| CO6280532A2 (es) | Derivados de isoquinolinona como antagonistas de nk3 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |